147 related articles for article (PubMed ID: 10483686)
1. [Phytogenic drugs in heart diseases exemplified by Crataegus].
Loew D
Wien Med Wochenschr; 1999; 149(8-10):226-8. PubMed ID: 10483686
[TBL] [Abstract][Full Text] [Related]
2. Phytotherapy in heart failure.
Loew D
Phytomedicine; 1997 Sep; 4(3):267-71. PubMed ID: 23195488
[TBL] [Abstract][Full Text] [Related]
3. [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
Rietbrock N; Hamel M; Hempel B; Mitrovic V; Schmidt T; Wolf GK
Arzneimittelforschung; 2001 Oct; 51(10):793-8. PubMed ID: 11715631
[TBL] [Abstract][Full Text] [Related]
4. Hawthorn extract improves chronic heart failure.
Eaton LJ; Kinkade S
J Fam Pract; 2003 Oct; 52(10):753-4. PubMed ID: 14529593
[No Abstract] [Full Text] [Related]
5. [Crataegus in cardiology].
Blesken R
Fortschr Med; 1992 May; 110(15):290-2. PubMed ID: 1634169
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of the enoximone clinical trials program.
Lowes BD; Shakar SF; Metra M; Feldman AM; Eichhorn E; Freytag JW; Gerber MJ; Liard JF; Hartman C; Gorczynski R; Evans G; Linseman JV; Stewart J; Robertson AD; Roecker EB; Demets DL; Bristow MR
J Card Fail; 2005 Dec; 11(9):659-69. PubMed ID: 16360960
[TBL] [Abstract][Full Text] [Related]
7. [Crataegus in heart failure and coronary heart disease. What is the value of this additional medication?].
MMW Fortschr Med; 2001 Feb; 143(6):56. PubMed ID: 11252428
[No Abstract] [Full Text] [Related]
8. Is the efficacy of positive inotropic drugs limited to symptomatic improvement?
Baumann G; Felix SB
Herz; 1991 Sep; 16 Spec No 1():304-13. PubMed ID: 1820297
[TBL] [Abstract][Full Text] [Related]
9. [Crataegus: a well regarded medicinal plant].
Ringl A
Wien Med Wochenschr; 1999; 149(8-10):225. PubMed ID: 10483685
[No Abstract] [Full Text] [Related]
10. Health effects of hawthorn.
Dahmer S; Scott E
Am Fam Physician; 2010 Feb; 81(4):465-8. PubMed ID: 20148500
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of decreasing cardiac performance. Therapy using standardized crataegus extract in advanced age].
O'Conolly M; Jansen W; Bernhöft G; Bartsch G
Fortschr Med; 1986 Nov; 104(42):805-8. PubMed ID: 3542766
[No Abstract] [Full Text] [Related]
12. [Rationale and clinical evidence for the effects of new pharmacological treatments for heart failure].
Tamargo J; López-Sendón J
Rev Esp Cardiol; 2004 May; 57(5):447-64. PubMed ID: 15151778
[TBL] [Abstract][Full Text] [Related]
13. Standardized extracts from hawthorn leaves and flowers in the treatment of cardiovascular disorders--preclinical and clinical studies.
Koch E; Malek FA
Planta Med; 2011 Jul; 77(11):1123-8. PubMed ID: 21384315
[TBL] [Abstract][Full Text] [Related]
14. Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
Habs M
Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():36-9. PubMed ID: 15353901
[TBL] [Abstract][Full Text] [Related]
15. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
Earl GL; Fitzpatrick JT
Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899
[TBL] [Abstract][Full Text] [Related]
16. [New inotropic drugs in chronic cardiac insufficiency: progress or wrong track].
Asseman P; Pruvost P; Lesenne M; Adnet P; Leroy F; Vigne JM; Delvallez L; Lacroix D; Thery C
Ann Cardiol Angeiol (Paris); 1988 Mar; 37(3):153-61. PubMed ID: 3284451
[TBL] [Abstract][Full Text] [Related]
17. [Refractory heart failure. Positive inotropes and beta blockers: alternative or complementary treatments?].
Sabbadini G; Ciaccheri M; Castelli G; Sinagra G; Di Lenarda A
Ital Heart J Suppl; 2002 Aug; 3(8):804-11. PubMed ID: 12407835
[TBL] [Abstract][Full Text] [Related]
18. Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy.
Stevenson LW
Circulation; 2003 Jul; 108(4):492-7. PubMed ID: 12885733
[No Abstract] [Full Text] [Related]
19. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic cardiovascular support.
Zaloga GP; Prielipp RC; Butterworth JF; Royster RL
Crit Care Clin; 1993 Apr; 9(2):335-62. PubMed ID: 8490766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
